Biden Administration Plans to Offer Second Booster Shots to Those 50 and Upnews2022-03-26T14:29:54+00:00March 26th, 2022|The New York Times|
F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science?news2022-03-25T15:15:07+00:00March 25th, 2022|The New York Times|
Moderna to Seek Authorization of Its Coronavirus Vaccine for Young Childrennews2022-03-23T22:18:57+00:00March 23rd, 2022|The New York Times|
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risknews2022-03-23T20:29:21+00:00March 23rd, 2022|The New York Times|
FDA Rejects India-Made Bharat Biotech Vaccine For Those Under 18news2022-03-04T22:04:38+00:00March 4th, 2022|The New York Times|
Senate Confirms Califf as F.D.A. Chief in Tight Votenews2022-02-15T18:47:59+00:00February 15th, 2022|The New York Times|
F.D.A. Clears Monoclonal Antibody Drug From Eli Lillynews2022-02-11T22:51:51+00:00February 11th, 2022|The New York Times|
¿Vacunar a los niños pequeños o esperar?news2022-02-11T18:08:17+00:00February 11th, 2022|The New York Times|
FDA Panel Rejects Lilly’s Cancer Drug Tested Only in Chinanews2022-02-10T22:41:51+00:00February 10th, 2022|The New York Times|
The Next Vaccine Debate: Immunize Young Children Now, or Wait?news2022-02-09T20:16:21+00:00February 9th, 2022|The New York Times|
